Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

5,948 total articles

DHT: Yield That Stands Up - Upgrade to Buy for a 45-Day Trade

DHT: Yield That Stands Up - Upgrade to Buy for a 45-Day Trade

DHT's cash-generative shipping operations, recent asset sales and newbuild deliveries materially improve liquidity and support a near-9% reported yield. We upgrade to a tactical Buy for a mid-term trade (45 trading days) with a clear entry, stop and target, balancing income capture and upside from improving earnings visibility.

Caledonia Mining: Bilboes Re-rates The Upside - Tactical Long Setup

Caledonia Mining: Bilboes Re-rates The Upside - Tactical Long Setup

Caledonia's Bilboes feasibility study materially increases theoretical upside by adding 1.749 Moz of reserves and a potential 200,000 oz/year first-full-year profile, but the project is years from production and sits alongside legacy Zimbabwe exposures. With the stock trading near $21 and a market cap of $405.7M, a disciplined swing trade can captu…

Levered Japan Play: Why EZJ Looks Poised for a Mid-Term Pop

Levered Japan Play: Why EZJ Looks Poised for a Mid-Term Pop

EZJ, a 2x leveraged ETF tracking the MSCI Japan Index, is trading near $66.05 with improving technicals, recent outperformance by Japan equities, and a compact market cap that makes intraday liquidity nuanced. This trade idea lays out a mid-term (45 trading days) long with tight risk controls to capture continued upside while acknowledging leverage…

Novo Nordisk: Deep Value Buy Ahead of a 2027 Growth Rebound

Novo Nordisk: Deep Value Buy Ahead of a 2027 Growth Rebound

Novo Nordisk is trading at roughly $43 with a market cap near $193B and a P/E of ~10. The market has punished the stock for near-term pricing and competition in GLP-1 drugs, but fundamentals - recurring revenue from diabetes and obesity care, an expanding oral Wegovy adoption, and a healthy dividend - argue for a re-rating if growth normalizes in 2…

AT&T: Deep Value, Growing FCF, and a Clear Path to Re-rating

AT&T: Deep Value, Growing FCF, and a Clear Path to Re-rating

AT&T trades at single-digit earnings multiples with a healthy free cash flow profile, a roughly 4.5% dividend yield, and a $19 billion California fiber commitment that demonstrates capital allocation toward durable growth assets. We present a long trade with disciplined risk controls that targets a meaningful multiple expansion while capturing inco…

Roku at 100M Homes: Underappreciated Ad Engine with Room to Run

Roku at 100M Homes: Underappreciated Ad Engine with Room to Run

Roku has cleared a key scale milestone - more than 100 million streaming households - and is turning that reach into accelerating platform revenue and free cash flow. The business mix is shifting from hardware to higher-margin ads and subscriptions; given improving profitability, robust FCF, and a still-conservative runway for ad monetization, I re…

Rocket Lab: Buying the Optionality on Neutron and a $2B Backlog

Rocket Lab: Buying the Optionality on Neutron and a $2B Backlog

Rocket Lab (RKLB) has posted rapid top-line growth and a backlog north of $2 billion while preparing the Neutron reusable rocket for a maiden flight by the end of 2026. At $123.31 the stock already prices a great deal of future optionality — this trade buys a defined-risk position ahead of key catalysts while acknowledging high valuation and execut…

Apple: AI Upside Without the Capex Drag - Upgrade to Buy

Apple: AI Upside Without the Capex Drag - Upgrade to Buy

Apple is benefitting from AI integration across its ecosystem without the heavy data-center capex that burdens other AI leaders. With recurring services growth, $129B in trailing free cash flow, and a $4.63T market cap trading at ~38x earnings, I upgrade AAPL to Buy and propose a mid-term swing trade to capture post-WWDC re-rating and continued iPh…

SAP at a Crossroads: Is the Turnaround Real? A Mid-Term Trade Plan

SAP at a Crossroads: Is the Turnaround Real? A Mid-Term Trade Plan

SAP's shares have retraced sharply from a $313 52-week high to the $190 area, but underlying momentum, a string of strategic AI and cloud moves, and rising short interest create a setup for a mid-term rebound. This trade idea lays out a concrete long entry at $191.00, a stop at $176.00 and a target at $240.00 over a mid-term (45 trading days) horiz…

Aurora Is Being Valued Like a Distressed Asset - VISN Looks Like the Cheap Arb Play vs. Ruckus Takeout Multiples

Aurora Is Being Valued Like a Distressed Asset - VISN Looks Like the Cheap Arb Play vs. Ruckus Takeout Multiples

Vistance Networks (VISN) is sitting on a compact, cash-rich balance sheet after the CCS divestiture and a material special distribution. The market currently prices the remaining business at EV/FCF ~1.3x and EV/EBITDA ~0.37x. If Aurora/Ruckus-like assets deserve anything near the 12-13x multiple paid by strategic buyers, VISN has meaningful upside.…